An underground market for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Experimental Treatment Gaining Traction Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are urged to message these accounts privately for supplier links, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Additionally, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Sellers promote the substance there before directing customers to other platforms for transactions.
Understanding The Experimental Drug
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Experts Voice Worries
Nevertheless, doctors and pharmacists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering products of unknown origin.
Several professionals stated the demand for the experimental drug could be connected to the rising cost of licensed slimming products such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach pharmaceutical, marketing, and consumer regulations, risking penalties, prosecution or prison.
Service Reaction and Material Removal
According to TikTok, the service has removed problematic material and prohibited related keywords and search suggestions. The company stated it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies.
Digital Trading Operations
Research also found groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with images of slimming results, positive reviews and detailed guides for preparing or administering at residence.
After moments of joining one group, a vendor shared contact information, where the majority of transactions occur. The vendor sent an guidebook and promised shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.
Item Details and Pricing
Within these groups, posts show black plastic parcels with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how much time a injector should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Service Moderation and Security Actions
A representative for Telegram said it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering materials they can’t verify. Although the research behind this drug is sound, these online products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.
Her staff has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject users to possibly significant health risks”.
